Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases
Open accessThe DOI matches its Crossref record; 100 of the 101 references it cites were found in a registry or an index.
Abstract
Inflammatory bowel diseases, which include Crohn’s disease and ulcerative colitis, affect several million individuals worldwide. Crohn’s disease and ulcerative colitis are complex diseases that are heterogeneous at the clinical, immunological, molecular, genetic, and microbial levels. Individual contributing factors have been the focus of extensive research. As part of the Integrative Human Microbiome Project (HMP2 or iHMP), we followed 132 subjects for one year each to generate integrated longitudinal molecular profiles of host and microbial activity during disease (up to 24 time points each; in total 2,965 stool, biopsy, and blood specimens). Here we present the results, which provide a comprehensive view of functional dysbiosis in the gut microbiome during inflammatory bowel disease activity. We demonstrate a characteristic increase in facultative anaerobes at the expense of obligate anaerobes, as well as molecular disruptions in microbial transcription (for example, among clostridia), metabolite pools (acylcarnitines, bile acids, and short-chain fatty acids), and levels of antibodies in host serum. Periods of disease activity were also marked by increases in temporal variability, with characteristic taxonomic, functional, and biochemical shifts. Finally, integrative analysis identified microbial, biochemical, and host factors central to this dysregulation. The study’s infrastructure resources, results, and data, which are available through the Inflammatory Bowel Disease Multi’omics Database ( http://ibdmdb.org ), provide the most comprehensive description to date of host and microbial activities in inflammatory bowel diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures













Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This relative absence of biomarkers for active UC may result both from its generally more benign phenotype (IBDMDB Investigators et al., 2019) and from the smaller number of active UC samples (n = 23) compared with active CD samples (n = 76); as a result, we focused our subsequent analyses on expression differences within the CD subcohort.”
From Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3 (2021) · cites this paper as IBDMDB Investigators et al., 2019
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This network of mechanistic associations identified several key components that are central to the alterations seen in IBD, highlighting octanoyl carnitine, several lipids and short-chain fatty acids, the taxa Faecalibacterium, Subdoligranulum, Roseburia, Alistipes, and Escherichia, some at both the metagenomic and metatranscriptomic levels, and host regulators of interleukins49.”
From The Integrative Human Microbiome Project (2019) · cites this paper as [49]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Multiple lines of evidence point towards central roles of gut microbiome perturbations in the pathogenesis of IBD.”
From Interaction between microbiota and immunity in health and disease (2020) · cites this paper as [152]
The cited source says what the claim attributes to it.
In the citing paper
“These studies, which have now reached the first stage of completion49–51, together provide a wealth of information and insights about not only microbial dynamics, but also associated human host responses and microbial inter-relationships.”
From The Integrative Human Microbiome Project (2019) · cites this paper as [49]
In the citing paper
“The authors could then use the 17 top taxa in their ranked list to identify which individuals are dysbiotic, an approach that demonstrated similar or better performance than the GMWI2 or another published metric called the “dysbiotic score”.195”
From Gut dysbiosis in oncology: a risk factor for immunoresistance (2026) · doi:10.1038/s41422-025-01212-6 · cites this paper as [195]
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cytoscape: A software Environment for integrated models of biomolecular interaction networks
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003) · Genome Research · doi:10.1101/gr.1239303 · Cited by 51,888
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364
limma powers differential expression analyses for RNA-sequencing and microarray studies
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458
PLINK: a tool set for whole-genome association and population-based linkage analyses.
Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A. R., Bender, D., Maller, J., Sklar, P., de Bakker, P. I. W., Daly, M. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/519795 · Cited by 34,089
Wickham, H. (2016) · Use R! · doi:10.1007/978-3-319-24277-4 · Cited by 33,115
Search and clustering orders of magnitude faster than BLAST
Edgar, R. C. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq461 · Cited by 20,826
A global reference for human genetic variation
The 1000 Genomes Project Consortium, authors, C., Auton, A., Abecasis, G. R., Steering committee, Altshuler, D. M., Durbin, R. M., Abecasis, G. R., Bentley, D. R., Chakravarti, A., et al. (2015) · Nature · doi:10.1038/nature15393 · Cited by 18,247
Self-citationUPARSE: highly accurate OTU sequences from microbial amplicon reads
Edgar, R. C. (2013) · Nature Methods · doi:10.1038/nmeth.2604 · Cited by 16,707
ggplot2: Elegant Graphics for Data Analysis
Wickham, H. (2009) · doi:10.1007/978-0-387-98141-3 · Cited by 14,447
Fast and sensitive protein alignment using DIAMOND
Buchfink, B., Xie, C., & Huson, D. H. (2015) · Nature Methods · doi:10.1038/nmeth.3176 · Cited by 14,201
Cited by
Items 501–600 of 1,010
Genetic Engineering of Resident Bacteria in the Gut Microbiome
Arnold, J. H., Glazier, J., & Mimee, M. (2023) · Journal of Bacteriology · doi:10.1128/jb.00127-23 · Cited by 67
Liu, A., Liang, X., Wang, W., Wang, C., Song, J., Guo, J., Sun, D., Wang, D., Mei, S., Qian, J., et al. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03471-9 · Cited by 67
“Besides host genetics, environmental factors especially gut microbiota, have been strongly associated with IBD initiation and progression [33].”
Inflammation and bacteriophages affect DNA inversion states and functionality of the gut microbiota
Carasso, S., Zaatry, R., Hajjo, H., Kadosh-Kariti, D., Ben-Assa, N., Naddaf, R., Mandelbaum, N., Pressman, S., Chowers, Y., Gefen, T., et al. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.02.003 · Cited by 70
Diverse plasmid systems and their ecology across human gut metagenomes revealed by PlasX and MobMess
Yu, M., Fogarty, E. C., & Eren, A. M. (2024) · Nature Microbiology · doi:10.1038/s41564-024-01610-3 · Cited by 76
“Although high-throughput analyses of human gut microbiomes often focus on taxonomic features, it has been challenging to find significant or reproducible taxonomic associations that distinguish health and disease states 47 .”
Balance between bile acid conjugation and hydrolysis activity can alter outcomes of gut inflammation
Fu, Y., Guzior, D. V., Okros, M., Bridges, C., Rosset, S. L., Gonzalez, C. T., Christian Martin, H., Karunarathne, H., Watson, V. E., & Quinn, R. A. (2025) · Nature Communications · doi:10.1038/s41467-025-58649-x · Cited by 76
Faecal microbial biomarkers in early diagnosis of colorectal cancer
Olovo, C. V., Huang, X., Zheng, X., & Xu, M. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17010 · Cited by 69
Drugs and Bugs: The Gut-Brain Axis and Substance Use Disorders
Simpson, S., Mclellan, R., Wellmeyer, E., Matalon, F., & George, O. (2021) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-021-10022-7 · Cited by 69
Pedersen, T. K., Brown, E., Plichta, D. R., Johansen, J., Twardus, S. W., Delorey, T. M., Lau, H., Vlamakis, H. C., Moon, J. J., Xavier, R. J., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.08.016 · Cited by 62
Self-citationSun, W., Chen, Y., Wang, L., Wang, Z., Liu, S., Zhang, M., Li, Q., Li, Q., & Zhang, H. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122039 · Cited by 63
Zhou, C., Wang, Y., Li, C., Xie, Z., & Dai, L. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.03330-22 · Cited by 66
“Overall, our study demonstrates that rationally designed bacterial consortia can reshape the metabolism of the gut microbiome and provides novel insights into the application of live biotherapeutics for treating IBD.”
BackgroundResultInfluentialOpportunities and barriers in omics-based biomarker discovery for steatotic liver diseases
Thiele, M. S., Villesen, I. F., Niu, L., Johansen, S., Sulek, K., Nishijima, S., Espen, L. V., Keller, M. I., Israelsen, M. E., Suvitaival, T., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.03.035 · Cited by 75
Role of Microbiome and Antibiotics in Autoimmune Diseases
Vangoitsenhoven, R., & Cresci, G. (2020) · Nutrition in Clinical Practice · doi:10.1002/ncp.10489 · Cited by 65
Plichta, D. R., Somani, J., Pichaud, M., Wallace, Z. S., Fernandes, A. D., Perugino, C. A., Lähdesmäki, H., Stone, J. H., Vlamakis, H., Chung, D. C., et al. (2021) · Genome Medicine · doi:10.1186/s13073-021-00853-7 · Cited by 59
Self-citationECCO Topical Review: Refractory Inflammatory Bowel Disease
Raine, T., Verstockt, B., Kopylov, U., Κarmiris, K., Goldberg, R., Atreya, R. N., Burisch, J. M., Burke, J. P., Ellul, P., Hedin, C. R. H., et al. (2021) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjab112 · Cited by 68
Microbiota in mesenteric adipose tissue from Crohn’s disease promote colitis in mice
He, Z., Wu, J., Gong, J., Ke, J., Ding, T., Zhao, W., Cheng, W. M., Luo, Z., He, Q., Zeng, W., et al. (2021) · Microbiome · doi:10.1186/s40168-021-01178-8 · Cited by 60
“Although multi-omics analysis of gut microbial ecosystem has been performed using feces or intestinal tissue of IBD patients [28, 29], system-level understanding of the etiology of mAT of CD patients has not been completed.”
BackgroundDoes probiotics work for bacterial vaginosis and vulvovaginal candidiasis
Yue, H., & Ren, Q. (2021) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2021.09.004 · Cited by 77
Verburgt, C. M., Dunn, K. A., Ghiboub, M., Lewis, J. D., Wine, E., Boneh, R. S., Gerasimidis, K., Shamir, R., Penny, S. L., Pinto, D. M., et al. (2022) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjac105 · Cited by 66
“Although Proteobacteria abundance had decreased when clinical remission was achieved with dietary therapy at Week 6, it was still increased compared with healthy controls [Figures 3 and 4].”
Lv, W., Ma, Y., Huang, J., He, S., Li, S.-P., Lin, J., Chen, R., Lun, J., Liu, J., & Guo, S. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.09.246 · Cited by 64
Omics and Multi-Omics in IBD: No Integration, No Breakthroughs
Fiocchi, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914912 · Cited by 67
Gut Microbiota Profile in Pediatric Patients With Inflammatory Bowel Disease: A Systematic Review
Zhuang, X., Liu, C., Zhan, S., Tian, Z., Li, N., Mao, R., Zeng, Z., & Chen, M. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.626232 · Cited by 65
“With advances in multi-omics methods, the study of gut microbial composition and function alterations in various diseases has emerged as a new potential area of clinical significance (16, 17).”
BackgroundEctopic gut colonization: a metagenomic study of the oral and gut microbiome in Crohn’s disease
Hu, S., Png, E., Gowans, M., Ong, D. E. H., de Sessions, P. F., Song, J., & Nagarajan, N. (2021) · Gut Pathogens · doi:10.1186/s13099-021-00409-5 · Cited by 70
“%) in both CD and healthy controls in this study were similar to previous studies employing WGS [10, 23].”
BackgroundMethodResultInfluentialThe taxonomic distribution of histamine-secreting bacteria in the human gut microbiome
Mou, Z., Yang, Y., Hall, A. B., & Jiang, X. (2021) · BMC Genomics · doi:10.1186/s12864-021-08004-3 · Cited by 62
Self-citationIdentification and Characterization of Major Bile Acid 7α-Dehydroxylating Bacteria in the Human Gut
Kim, K. H., Park, D., Jia, B., Baek, J. H., Hahn, Y., & Jeon, C. O. (2022) · mSystems · doi:10.1128/msystems.00455-22 · Cited by 73
“These results suggest that bacterial groups harboring baiE genes of cluster 1 may be the most important 7a-dehydroxylating bacteria associated with the occurrence of IBD in the human gut.”
InfluentialWang, S., van Schooten, F., Jin, H., Jonkers, D. M. A. E., & Godschalk, R. (2023) · Nutrients · doi:10.3390/nu15132886 · Cited by 60
Kuffa, P., Pickard, J. M., Campbell, A., Yamashita, M., Schaus, S. R., Martens, E. C., Schmidt, T. M., Inohara, N., Núñez, G., & Caruso, R. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.10.016 · Cited by 58
Wu, X., Zhang, T., Zhang, T., & Park, S. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2292254 · Cited by 65
“27 In the pre-sent study, butyrate producers such as A. hadrus and O. splanchnicus were significantly reduced in the ET-B UC group.”
BackgroundXie, H., Yu, S. B., Tang, M., Xun, Y., Shen, Q., & Wu, G. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1608025 · Cited by 91
Cassotta, M., Forbes-Hernández, T. Y., Iglesias, R. C., Ruíz, R., Elexpuru-Zabaleta, M., Giampieri, F., & Battino, M. A. (2020) · Nutrients · doi:10.3390/nu12061827 · Cited by 62
Brand, E. C., Klaassen, M. A. Y., Gaćeša, R., Vila, A. V., Ghosh, H., de Zoete, M. R., Boomsma, D. I., Hoentjen, F., Horje, C. S. H. T., van de Meeberg, P. C., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.01.030 · Cited by 63
Nutrition and Rheumatoid Arthritis in the ‘Omics’ Era
Cassotta, M., Forbes-Hernández, T. Y., Cianciosi, D., Elexpuru-Zabaleta, M., Cano, S. S., Azpíroz, I. D., Bullón, B., Regolo, L., Álvarez-Suárez, J. M., Giampieri, F., et al. (2021) · Nutrients · doi:10.3390/nu13030763 · Cited by 65
Březina, J., Bajer, L., Wohl, P., Ďuricová, D., Hrabák, P., Novotný, A., Koželuhová, J., Lukáš, M., Mrázek, J., Fliegerová, K. O., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10132753 · Cited by 56
“Compared with the general population, the gut microbiome in patients with UC is significantly less diverse and less stable over time [1,2].”
BackgroundVincenzo, F. D., Puca, P., Lopetuso, L. R., Petito, V., Masi, L., Bartocci, B., Murgiano, M., Felice, M. D., Petronio, L., Gasbarrini, A., et al. (2022) · Nutrients · doi:10.3390/nu14132664 · Cited by 64
“A multi-omics profiling of 103 IBD patients showed a significant reduction in SBA, LCA, and DCA and an enrichment of CA and its glycine and taurine conjugates in stool samples of CD patients with dysbiosis compared with those without dysbiosis [25].”
BackgroundMicrobiome and metabolome in inflammatory bowel disease
Upadhyay, K. G., Desai, D., Ashavaid, T. F., & Dherai, A. J. (2022) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16043 · Cited by 66
Alexander, J. L., Mullish, B. H., Danckert, N. P., Liu, Z., Olbei, M. L., Saifuddin, A., Torkizadeh, M., Ibraheim, H., Blanco, J. M., Roberts, L. A., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2022.104430 · Cited by 61
Serum amyloid protein A in inflammatory bowel disease: from bench to bedside
Chen, R., Chen, Q., Zheng, J., Zeng, Z., Chen, M., Li, L., & Zhang, S. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01455-5 · Cited by 65
“5 when compared to participants without IBD [89].”
BackgroundLemons, J. M. S., Conrad, M. A., Tanes, C., Chen, J., Friedman, E. S., Roggiani, M., Curry, D., Chau, L., Hecht, A. L., Harling, L. C., et al. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.09.005 · Cited by 64
“12,13 To determine whether similar associations could be observed in a prospective cohort of patients with pediatric ulcerative colitis (UC)/IBD unclassi fi ed (IBD-U) 28 and Crohn ’ s disease (CD), as well as identify correlations with disease phenotype and activity, we analyzed fecal…”
BackgroundMethodInfluentialZhu, Y., Huang, X., Deng, Z., Bai, T., Gao, B., Xu, C., Fu, J., Zhao, Y., Zhang, Y., Zhang, M., et al. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02802-z · Cited by 65
“…is that a combination of factors, such as genetic predisposition [4], abnormal immune regulation [5–7], changes in the intestinal microbiota [8, 9], and external environmental stimuli [10, 11], contribute to a dysregulation of intestinal homeostasis, which in turn triggers inflammatory…”
BackgroundFang, X., Liu, H., Liu, J., Du, Y., Chi, Z., Bian, Y., Zhao, X., Teng, T., & Shi, B. (2025) · Research · doi:10.34133/research.0673 · Cited by 65
The microbiota and immune‐mediated diseases: Opportunities for therapeutic intervention
Fitzgibbon, G., & Mills, K. H. G. (2020) · European Journal of Immunology · doi:10.1002/eji.201948322 · Cited by 62
Tierney, B. T., Tan, Y., Kostic, A. D., & Patel, C. J. (2021) · Nature Communications · doi:10.1038/s41467-021-23029-8 · Cited by 64
“The underlying curated datasets are from 2018 and since then many studies for the various diseases have been published, e.g. for IBD (Lloyd-Price et al, 2019 Nature).”
BackgroundMethodDowdell, A. S., & Colgan, S. P. (2021) · Pharmaceuticals · doi:10.3390/ph14080708 · Cited by 56
Stražar, M., Park, J., Abelin, J. G., Taylor, H. B., Pedersen, T. K., Plichta, D. R., Brown, E., Eraslan, B., Hung, Y.-M., Ortiz, K., et al. (2023) · Immunity · doi:10.1016/j.immuni.2023.05.009 · Cited by 65
Self-citationMeade, S., Kiow, J. L. C., Massaro, C. A., Kaur, G., Squirell, E., Bressler, B. L., & Lunken, G. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2287073 · Cited by 68
A review on the use of prebiotics in ulcerative colitis
Kennedy, J. M., Silva, A. D., Walton, G., & Gibson, G. R. (2023) · Trends in Microbiology · doi:10.1016/j.tim.2023.11.007 · Cited by 67
“Whereas the majority of studies to date have examined relative abundances of different bacteria in the colonic microbiota, focus has shifted towards a functional view of the gut microbiome in IBD, using metagenomics and metatranscriptomics [30].”
Urbauer, E., Aguanno, D., Mindermann, N., Omer, H., Metwaly, A., Krammel, T., Faro, T., Remke, M., Reitmeier, S., Bärthel, S., et al. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.06.013 · Cited by 65
Population-specific differences in the human microbiome: Factors defining the diversity
Govender, P., & Ghai, M. (2024) · Gene · doi:10.1016/j.gene.2024.148923 · Cited by 68
Lin, X. F., Xu, M., Lan, R., Hu, D., Zhang, S., Zhang, S., Lu, Y., Sun, H., Yang, H. J., Liu, L., et al. (2025) · mSystems · doi:10.1128/msystems.01607-24 · Cited by 76
“of 132 subjects and 2,965 biological samples (stool, biopsy, and blood specimens) also showed a low relative abundance of A . s hahii in the two most prevalent forms of IBD, dysbiotic ulcerative colitis (UC) and Crohn’s disease (CD) (5).”
Gut Microbiota Serves as a Crucial Independent Biomarker in Inflammatory Bowel Disease (IBD)
Sharma, B., Agriantonis, G., Twelker, K., Ebelle, D., Kiernan, S., Siddiqui, M., Soni, A., Cheerasarn, S., Simon, W., Jiang, W., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062503 · Cited by 65
Porcari, S., CICCARESE, C., Heidrich, V., Rondinella, D., Quaranta, G., Severino, A., Arduini, D., Buti, S., Fornarini, G., Primi, F., et al. (2026) · Nature Medicine · doi:10.1038/s41591-025-04189-2 · Cited by 69
Jones, C. M. A., Connors, J., Dunn, K. A., Bielawski, J. P., Comeau, A., Langille, M. G. I., & Limbergen, J. V. (2020) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaa001 · Cited by 62
Gut Microbial Dysbiosis and Plasma Metabolic Profile in Individuals With Vitiligo
Ni, Q., Ye, Z., Wang, Y., Chen, J., Zhang, W., Ma, C., Li, K., Liu, Y., Liu, L., Han, Z., et al. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.592248 · Cited by 66
“, 2019), another autoimmune disease associated with aberrant intestinal microbiome (Gevers et al., 2014; Lloyd-Price et al., 2019).”
BackgroundUpdate: Innate Lymphoid Cells in Inflammatory Bowel Disease
Luo, W., Tian, L., Tan, B., Shen, Z., Xiao, M., Wu, S., Meng, X., Wu, X., & Wang, X. (2021) · Digestive Diseases and Sciences · doi:10.1007/s10620-021-06831-8 · Cited by 60
“, by upregulating the kynurenine pathway and inhibiting the indole pathway [95, 96].”
BackgroundCheng, S., Hu, J., Wu, X., Pan, J.-A., Jiao, N., Li, Y., Huang, Y., Lin, X., Zou, Y., Chen, Y., et al. (2021) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2021.08.003 · Cited by 59
The critical role of tumor microbiome in cancer immunotherapy
Yang, L., Wang, Q., He, L., & Sun, X. (2024) · Cancer Biology & Therapy · doi:10.1080/15384047.2024.2301801 · Cited by 55
“47 Machine learning and bioinformatics tools are essential in analyzing and interpreting the vast amount of multi-omics data generated from these approaches.”
BackgroundA Broad m6A Modification Landscape in Inflammatory Bowel Disease
Nie, K., Yi, J., Yang, Y., Deng, M., Yang, Y. X., Wang, T., Chen, X., Zhang, Z., & Wang, X. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.782636 · Cited by 64
“For example, validation cohort IBDMDB is part of the American National Institute of Health’s integrative human microbiome project (HMP2/iHMP) (Lloyd-Price et al., 2019).”
BackgroundMethodMulti-Omics Analysis Reveals Aberrant Gut-Metabolome-Immune Network in Schizophrenia
Fan, Y., Gao, Y., Ma, Q., Yang, Z., Zhao, B., He, X., Yang, J., Yan, B., Gao, F., Li, Q., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.812293 · Cited by 67
Local barriers configure systemic communications between the host and microbiota
Lu, Q., & Stappenbeck, T. S. (2022) · Science · doi:10.1126/science.abo2366 · Cited by 57
Self-citationEmodin targeting the colonic metabolism via PPARγ alleviates UC by inhibiting facultative anaerobe
Luo, S., He, J., Huang, S., Wang, X., Su, Y., Li, Y., Chen, Y., Yang, G., Huang, B., Guo, S., et al. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154106 · Cited by 59
Fecal microbiota and bile acids in IBD patients undergoing screening for colorectal cancer
Lavelle, A., Nancey, S., Reimund, J., Laharie, D., Marteau, P. R., Tréton, X., Allez, M., Roblin, X., Malamut, G., Oeuvray, C., et al. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2078620 · Cited by 62
“3, has already been linked to IBD in multiple studies.(8,35,36) Interestingly, R.”
BackgroundSugihara, K., Kitamoto, S., Saraithong, P., Nagao‐Kitamoto, H., Hoostal, M. J., McCarthy, C., Rosevelt, A., Muraleedharan, C. K., Gillilland, M. G., Imai, J., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111093 · Cited by 58
Huang, Z., Liu, K., Ma, W., Li, D., Mo, T., & Liu, Q. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1018594 · Cited by 75
Sohn, J., Li, L., Zhang, L., Genco, R. J., Falkner, K. L., Tettelin, H., Rowsam, A. M., Smiraglia, D. J., Novak, J. M., Diaz, P. I., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112120 · Cited by 61
“1,3 However, only a few studies investigated the effect of PD on the gut microbiome of patients with CD. 10 As previously reported, we observed a reduced fecal alpha diversity and an alteration in fecal beta diversity associated with CD. 1 Interestingly, subgroup correlation analysis showed that…”
BackgroundResultClinical sequelae of gut microbiome development and disruption in hospitalized preterm infants
Thänert, R., Schwartz, D. J., Keen, E. C., Hall-Moore, C. M., Wang, B., Shaikh, N., Ning, J., Rouggly-Nickless, L. C., Thänert, A., Ferreiro, A. L., et al. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.07.027 · Cited by 64
Gut microbiota in regulatory T cell generation and function: mechanisms and health implications
Sharma, A., Sharma, G., & Im, S. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2516702 · Cited by 71
“33 Additionally, this was accompanied by a significant reduction in Subdoligranulum sp., which forms a complex of new species-level clade with at least seven butyrate producer species of Subdoligranulum , Gemmiger , and Faecalibacterium genera.”
InfluentialThe human microbiome in clinical translation: from bench to bedside
Bautista, J., Echeverría, C. E., Maldonado-Noboa, I., Ojeda-Mosquera, S., Hidalgo-Tinoco, C., & López-Cortés, A. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1632435 · Cited by 55
Whole exome sequencing analyses reveal gene–microbiota interactions in the context of IBD
Hu, S., Vich Vila, A., Gacesa, R., Collij, V., Stevens, C., Fu, J. M., Wong, I., Talkowski, M. E., Rivas, M. A., Imhann, F., et al. (2021) · Gut · doi:10.1136/gutjnl-2019-319706 · Cited by 54
“18 The lack of replication of other studies including Lloyd-Price et al 27 could partially be explained by the cohort recruitment, for example, Groningen patients with IBD are over 18 years old with long-term disease problems while half of the patients in Lloyd-Price et al are early onset…”
Self-citationDiscovery of disease-adapted bacterial lineages in inflammatory bowel diseases
Kumbhari, A., Cheng, T. N. H., Ananthakrishnan, A. N., Kochar, B., Burke, K. E., Shannon, K., Lau, H., Xavier, R. J., & Smillie, C. S. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.05.022 · Cited by 54
Self-citationJiang, Z., Li, J., Kong, N., Kim, J.-H., Kim, B.-S., Lee, M.-J., Park, Y. M., Lee, S.-Y., Hong, S.-J., & Sul, J. H. (2022) · Scientific Reports · doi:10.1038/s41598-021-04373-7 · Cited by 54
Production of New Microbially Conjugated Bile Acids by Human Gut Microbiota
García, C. J., Kosek, V., Beltrán, D., Tomás-Barberán, F. A., & Hajšlová, J. (2022) · Biomolecules · doi:10.3390/biom12050687 · Cited by 61
“A multi-omics study including 123 subjects affected with inflammatory bowel disease showed an increase in both the BAs and in facultative anaerobes [17,18].”
BackgroundMetabolome Changes With Diet-Induced Remission in Pediatric Crohn’s Disease
Ghiboub, M., Penny, S. L., Verburgt, C. M., Boneh, R. S., Wine, E., Cohen, A., Dunn, K. A., Pinto, D. M., Benninga, M. A., de Jonge, W. J., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.05.050 · Cited by 61
Paine, A., Brookes, P. S., Bhattacharya, S., Li, D., García-Hernández, M. D. L. L., Tausk, F., & Ritchlin, C. T. (2022) · Arthritis & Rheumatology · doi:10.1002/art.42288 · Cited by 57
“Decreased serum bile acid levels are associated with several immune-mediated inflammatory diseases, including multiple sclerosis (23), inflammatory bowel disease (34), and psoriasis (35).”
BackgroundThe role of gut microbiome in inflammatory bowel disease diagnosis and prognosis
Zheng, J., Sun, Q., Zhang, J., & Ng, S. C. (2022) · United European Gastroenterology Journal · doi:10.1002/ueg2.12338 · Cited by 60
“Metagenomic analysis, plus targeted and untargeted metabolomics analysis have been utilized to investigate the function of microbiota‐derived metabolites and the importance and variation of metabolites from feces, urine, and serum between IBD patients and healthy controls.(93,94) Some bacterial‐associated metabolites,…”
Thompson, K. N., Bonham, K. S., Ilott, N. E., Britton, G. J., Colmenero, P., Bullers, S. J., McIver, L. J., Ma, S., Nguyen, L. H., Filer, A. D., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abn4722 · Cited by 59
Self-citationLiu, L., Wang, H., Rao, X., Yu, Y., Li, W., Zheng, P., Zhao, L., Zhou, C., Pu, J., Yang, D., et al. (2020) · Journal of Advanced Research · doi:10.1016/j.jare.2020.12.002 · Cited by 59
“Findings from multi-omics studies of the microbiome, including the HMP, have elucidated the mechanisms of host–microbiota interactions during pregnancy and in preterm birth [4], type 2 diabetes [5], and inflammatory bowel disease [6].”
BackgroundYoung, C., Wood, H. M., Seshadri, R. A., Nang, P. V., Vaccaro, C. A., Contreras, L., Bose, M., Doi, M. V., Piñero, T. A., Valladares, C. T., et al. (2021) · Genome Medicine · doi:10.1186/s13073-021-00844-8 · Cited by 60
Self-citationSayavedra, L., Li, T., Batista, M. B., Seah, B. K. B., Booth, C., Zhai, Q., Chen, W., & Narbad, A. (2021) · Environmental Microbiology · doi:10.1111/1462-2920.15538 · Cited by 61
Bourgonje, A. R., Roo-Brand, G., Lisotto, P., Sadaghian Sadabad, M., Reitsema, R. D., de Goffau, M. C., Faber, K. N., Dijkstra, G., & Harmsen, H. J. M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.842911 · Cited by 47
“, Enterocloster bolteae and Enterocloster clostridioforme, or Ruminococcus gnavus belonging to the family of Lachnospiraceae) belonging to these bacterial genera are flagellated (10, 36, 37).”
BackgroundBile acids: Key players in inflammatory bowel diseases?
Kriaa, A., Mariaule, V., Jablaoui, A., Rhimi, S., Mkaouar, H., Hernandez, J., Korkmaz, B., Lesner, A., Maguin, E., Aghdassi, A., et al. (2022) · Cells · doi:10.3390/cells11050901 · Cited by 53
“Similar differences in the composition of BAs have been reported in other studies exploring fecal metabolite pools in IBD patients [11,12].”
BackgroundResultMucosal vitamin D signaling in inflammatory bowel disease
Kellermann, L., Jensen, K. B., Bergenheim, F. H., Gubatan, J. M. B., Chou, N. D., Moss, A. C., & Nielsen, O. H. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102672 · Cited by 55
The gut virome in inflammatory bowel diseases
Liang, G., Güemes, A. G. C., Albenberg, L. G., & Bushman, F. D. (2021) · Current Opinion in Virology · doi:10.1016/j.coviro.2021.10.005 · Cited by 55
tRNA queuosine modification is involved in biofilm formation and virulence in bacteria
Díaz-Rullo, J., & González‐Pastor, J. E. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad667 · Cited by 59
Metabolic network of the gut microbiota in inflammatory bowel disease
Sugihara, K., & Kamada, N. (2024) · Inflammation and Regeneration · doi:10.1186/s41232-024-00321-w · Cited by 67
“Consistent with the animal studies, fiber-fer-mented bacteria, including F. prausnitzii and Roseburia hominis , and fecal levels of SCFAs are lower in IBD than those in healthy controls [90].”
Recent advances in bacteria‐based platforms for inflammatory bowel diseases treatment
Lu, J., Shen, X., Li, H., & Du, J. (2024) · Exploration · doi:10.1002/exp.20230142 · Cited by 65
Artificial intelligence to revolutionize IBD clinical trials: a comprehensive review
Sedaño, R., Solitano, V., Vuyyuru, S. K., Yuan, Y., Hanžel, J., Ma, C., Nardone, O. M., & Jairath, V. (2025) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848251321915 · Cited by 68
Identifying determinants of bacterial fitness in a model of human gut microbial succession
Feng, L., Raman, A. S., Hibberd, M. C., Cheng, J., Griffin, N. W., Peng, Y., Leyn, S. A., Rodionov, D. A., Osterman, A. L., & Gordon, J. I. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1918951117 · Cited by 54
Intestinal Microbes in Autoimmune and Inflammatory Disease
Wu, W.-J. H., Zegarra-Ruiz, D. F., & Diehl, G. E. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.597966 · Cited by 57
The fecal mycobiome in patients with Irritable Bowel Syndrome
Das, A., O’Herlihy, E. A., Shanahan, F., O’Toole, P. W., & Jeffery, I. B. (2021) · Scientific Reports · doi:10.1038/s41598-020-79478-6 · Cited by 60
New technologies for developing phage-based tools to manipulate the human microbiome
Khan Mirzaei, M., & Deng, L. (2022) · Trends in Microbiology · doi:10.1016/j.tim.2021.04.007 · Cited by 53
“Multiple metabolites are also involved, such as acylcarnitines, bile acids, and short-chain fatty acids – making any intervention more challenging [10].”
BackgroundInfluentialBakır-Güngör, B., Hacılar, H., Jabeer, A., Nalbantoğlu, Ö. U., Aran, O., & Yousef, M. (2022) · PeerJ · doi:10.7717/peerj.13205 · Cited by 60
Effects of oral milk extracellular vesicles on the gut microbiome and serum metabolome in mice
Du, C., Quan, S., Nan, X., Zhao, Y., Shi, F., Luo, Q., & Xiong, B. (2021) · Food & Function · doi:10.1039/d1fo02255e · Cited by 54
Radhakrishnan, S. T., Alexander, J. L., Mullish, B. H., Gallagher, K., Powell, N., Hicks, L., Hart, A. L., Li, J. V., Marchesi, J. R., & Williams, H. R. T. (2021) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16656 · Cited by 60
Yao, Z., Zhang, B., Niu, G., Yan, Z., Tong, X., Zou, Y., Yuan, L., & Yang, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.896645 · Cited by 56
Dysbiotic Oral and Gut Viromes in Untreated and Treated Rheumatoid Arthritis Patients
Guo, R., Li, S., Zhang, Y., Zhang, Y., Wang, G., Ullah, H., Ma, Y., & Yan, Q. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00348-22 · Cited by 55
Searching for a Consensus Among Inflammatory Bowel Disease Studies: A Systematic Meta-Analysis
Abdel-Rahman, L. I. H., & Morgan, X. C. (2022) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izac194 · Cited by 58
Lv, Y., Ren, M., Yao, M., Zou, J., Fang, S., Wang, Y., Lan, M., Zhao, Y., & Gao, F. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.122741 · Cited by 56
Wang, T., Wang, X., Lee‐Sarwar, K. A., Litonjua, A. A., Weiss, S. T., Sun, Y., Maslov, S., & Liu, Y. (2023) · Nature Machine Intelligence · doi:10.1038/s42256-023-00627-3 · Cited by 59
“such as essential amino acids [5] and short-chain fatty acids [2], which are crucial for human well-being [6, 7, 8].”
BackgroundGao, X., Sun, R., Jiao, N., Liang, X., Li, G., Gao, H., Wu, X., Yang, M., Chen, C., Sun, X., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101050 · Cited by 57
“Crohn disease (CD), a type of inflammatory bowel disease (IBD), is a chronic intestinal disorder involving any part of the gastrointestinal tract and is characterized by transmural inflammation,1 globally afflicting more than 3.5 million individuals.2 Multiple factors, including genetic susceptibility, immune dysregul…”
BackgroundInfluentialCiaula, A. D., Bonfrate, L., Khalil, M., & Portincasa, P. (2023) · Internal and Emergency Medicine · doi:10.1007/s11739-023-03343-3 · Cited by 59
“In IBD patients, variations in the relative abundance of mucosa-adherent microorganisms are able to modulate the expression of several host genes [40, 127, 128], and an altered BA homeostasis seems to have a critical role in this process [129].”
BackgroundChang, D., Gupta, V. K., Hur, B., Cobo-López, S., Cunningham, K. Y., Han, N. S., Lee, I., Kronzer, V. L., Teigen, L. M., Karnatovskaia, L. V., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51651-9 · Cited by 50
Mima, K., Kosumi, K., Baba, Y., Hamada, T., Baba, H., & Ogino, S. (2020) · Human Genetics · doi:10.1007/s00439-020-02235-2 · Cited by 53
Metadata
- Authors
- Lloyd-Price, J., Arze, C., Ananthakrishnan, A. N., Schirmer, M., Avila-Pacheco, J., Poon, T. W., Andrews, E., Ajami, N. J., Bonham, K. S., Brislawn, C. J., Casero, D., Courtney, H., Gonzalez, A., Graeber, T. G., Hall, A. B., Lake, K., Landers, C. J., Mallick, H., Plichta, D. R., Prasad, M., Rahnavard, G., Sauk, J., Shungin, D., Vázquez-Baeza, Y., White, R. A., IBDMDB Investigators, Bishai, J., Bullock, K., Deik, A., Dennis, C., Kaplan, J. L., Khalili, H., McIver, L. J., Moran, C. J., Nguyen, L., Pierce, K. A., Schwager, R., Sirota-Madi, A., Stevens, B. W., Tan, W., ten Hoeve, J. J., Weingart, G., Wilson, R. G., Yajnik, V., Braun, J., Denson, L. A., Jansson, J. K., Knight, R., Kugathasan, S., McGovern, D. P. B., Petrosino, J. F., Stappenbeck, T. S., Winter, H. S., Clish, C. B., Franzosa, E. A., Vlamakis, H., Xavier, R. J., & Huttenhower, C.
- Affiliations
- Harvard University (US)
- Massachusetts General Hospital (US)
- Broad Institute (US)
- Baylor College of Medicine (US)
- Pacific Northwest National Laboratory (US)
- University of California, Los Angeles (US)
- Cincinnati Children's Hospital Medical Center (US)
- Cedars-Sinai Medical Center (US)
- Emory University (US)
- University of California San Diego (US)
- Washington University in St. Louis (US)
- Corresponding author
- Huttenhower, Curtis
- ORCID
- Arze, Cesar
- Ananthakrishnan, Ashwin N.
- Schirmer, Melanie
- Ajami, Nadim J.
- Bonham, Kevin S.
- Brislawn, Colin J.
- Casero, David
- Graeber, Thomas G.
- Hall, A. Brantley
- Mallick, Himel
- Plichta, Damian R.
- Sauk, Jenny
- Shungin, Dmitry
- Bullock, Kevin
- Deik, Amy
- Khalili, Hamed
- McIver, Lauren J.
- Nguyen, Long
- Pierce, Kerry A.
- Yajnik, Vijay
- Knight, Rob
- McGovern, Dermot P. B.
- Winter, Harland S.
- Clish, Clary B.
- Franzosa, Eric A.
- Vlamakis, Hera
- Xavier, Ramnik J.
- Huttenhower, Curtis
- Venue
- Nature
- Published
- 2019-05-29
- Volume
- 569
- Issue
- 7758
- Pages
- 655-662
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC6650278
- OpenAlex
- W2947189704
- Cited by
- 3,143
- References
- 101
- Citations by year
- 2026: 500 · 2025: 555 · 2024: 498 · 2023: 402 · 2022: 441 · 2021: 452 · 2020: 247 · 2019: 42
- FWCI
- 98.40
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- National Science Foundation (1053486, DEAC05–76RL01830, 76RL01830)
- U.S. Department of Energy (DE-AC05–76RL01830, 76RL01830, AC05-76RL01830, DE-AC05?)
- Battelle (AC05-76RL01830, DE- AC05-76RL01830, DE-AC05)
- Leona M. and Harry B. Helmsley Charitable Trust (P01DK046763, U01DK062413)
- Harvard T.H. Chan School of Public Health
- Crohn's and Colitis Foundation (563526)
- Broad Institute
- Vetenskapsrådet (4.1-2016-00416)
- National Institutes of Health (DBI-1053486, UL1TR001881, DE-AC05-76RL01830)
- National Human Genome Research Institute (R01HG005969)
- National Institute of Diabetes and Digestive and Kidney Diseases (P01DK046763, R24DK110499, U54DK102557, U01DK062413, P30DK078392, P30DK043351, P30DK040561)
- National Institute of Dental and Craniofacial Research (U54DE023798)
- National Center for Advancing Translational Sciences
- Army Research Office (W911NF-11-1-0473, W911NF, W911NF-11)
- Pacific Northwest National Laboratory (DEAC0576RL01830, 76RL01830)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- inflammatory bowel disease, Crohn's disease, ulcerative colitis, gut microbiota, dysbiosis, multi-omics, facultative anaerobes, obligate anaerobes, Clostridia, acylcarnitines, bile acids, short-chain fatty acids, serum antibodies, disease activity, temporal variation, host-microbe interactions
- MeSH terms
- Gastrointestinal Microbiome, Animals, Fungi, Health, Humans, Phylogeny, Species Specificity, Viruses, Inflammatory Bowel Diseases, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.